46 results on '"Pchejetski, Dmitri"'
Search Results
2. Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups
3. Bradycardia and syncope as sole manifestations of a cranial lesion: a case report
4. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
5. Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications
6. MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA TEST IN THE PROSTAGRAM TRIAL
7. Data from FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
8. Supplementary Figures 11-14 from FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
9. Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection
10. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
11. Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
12. Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells
13. Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer
14. Additional file 1 of Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups
15. Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer
16. Castrate-resistant prostate cancer: the future of antiandrogens
17. Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profiling
18. Therapeutic Potential of Targeting SK1 in Human Cancers
19. 3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcome
20. A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia
21. Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
22. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer
23. The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1a protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6
24. Dynamic early identification of hip replacement implants with high revision rates. Study based on the NJR data from UK during 2004-2012
25. Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target
26. Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
27. MP35-13 WHITE BLOOD CELLS FROM PROSTATE CANCER PATIENTS CARRY DISTINCT CHROMOSOME CONFORMATIONS
28. Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
29. Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1
30. An unusual case of disseminated intravascular coagulation
31. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
32. Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer
33. The emerging role of FTY720 (Fingolimod) in cancer treatment
34. Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
35. Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
36. Circulating chromatin conformation signatures to enhance PSA positive predictive value and overall accuracy for prostate cancer detection.
37. Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer
38. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway
39. Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage
40. Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage
41. Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
42. FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
43. The involvement of sphingosine kinase 1 in LPS‐induced Toll‐like receptor 4‐mediated accumulation of HIF‐1α protein, activation of ASK1 and production of the pro‐inflammatory cytokine IL‐6
44. Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer.
45. Therapeutic potential of targeting SK1 in human cancers.
46. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.